These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

744 related items for PubMed ID: 33875857

  • 1. Endocrine toxicities of immune checkpoint inhibitors.
    Wright JJ, Powers AC, Johnson DB.
    Nat Rev Endocrinol; 2021 Jul; 17(7):389-399. PubMed ID: 33875857
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System.
    Raschi E, Mazzarella A, Antonazzo IC, Bendinelli N, Forcesi E, Tuccori M, Moretti U, Poluzzi E, De Ponti F.
    Target Oncol; 2019 Apr; 14(2):205-221. PubMed ID: 30927173
    [Abstract] [Full Text] [Related]

  • 5. Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis.
    Barroso-Sousa R, Barry WT, Garrido-Castro AC, Hodi FS, Min L, Krop IE, Tolaney SM.
    JAMA Oncol; 2018 Feb 01; 4(2):173-182. PubMed ID: 28973656
    [Abstract] [Full Text] [Related]

  • 6. Endocrine immune-related adverse effects of immune-checkpoint inhibitors.
    Trevisani V, Iughetti L, Lucaccioni L, Predieri B.
    Expert Rev Endocrinol Metab; 2023 Feb 01; 18(5):441-451. PubMed ID: 37682107
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The side effects of immune checkpoint inhibitor therapy on the endocrine system.
    Goyal I, Pandey MR, Sharma R, Chaudhuri A, Dandona P.
    Indian J Med Res; 2021 Apr 01; 154(4):559-570. PubMed ID: 35435341
    [Abstract] [Full Text] [Related]

  • 14. Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine Society.
    Kwon H, Roh E, Ahn CH, Kim HK, Ku CR, Jung KY, Lee JH, Kim EH, Suh S, Hong S, Ha J, Moon JS, Kim JH, Kim MK, Committee of Clinical Practice Guideline of the Korean Endocrine Society.
    Endocrinol Metab (Seoul); 2022 Dec 01; 37(6):839-850. PubMed ID: 36604955
    [Abstract] [Full Text] [Related]

  • 15. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicities.
    Cooksley T, Girotra M, Ginex P, Gordon RA, Anderson R, Blidner A, Choi J, Dougan M, Glezerman I, Gupta D, Johnson D, Shannon VR, Suarez-Almazor M, Rapoport BL.
    Support Care Cancer; 2020 Dec 01; 28(12):6175-6181. PubMed ID: 32856213
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies.
    Byun DJ, Wolchok JD, Rosenberg LM, Girotra M.
    Nat Rev Endocrinol; 2017 Apr 01; 13(4):195-207. PubMed ID: 28106152
    [Abstract] [Full Text] [Related]

  • 19. Endocrine side effects of immune checkpoint inhibitors.
    Cardona Z, Sosman JA, Chandra S, Huang W.
    Front Endocrinol (Lausanne); 2023 Apr 01; 14():1157805. PubMed ID: 37251665
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.